Figure 1. Chronic inflammatory diseases initiate mixed innate and adaptive immune responses and may cause tissue injury and organ dysfunction. Hyperlipidemia, repeated tissue traumata, chronic ...

InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...

mRNA vaccines represent a transformative advance in vaccinology, combining rapid development timelines, scalable manufacturing, and strong immunogenicity with a favourable safety profile. Global ...

Patients with end-stage kidney disease who have spent years on transplant waitlists now face a new clinical reality: two ...

The wAIHA market landscape is undergoing a significant evolution after years of dependence on broad immunosuppressive ...